How to Track Peptides, GLP-1 Shots, and Everything Around Them

Why peptide and GLP-1 regimens are so easy to lose track of

Most peptide and GLP-1 regimens are not complicated. They are just badly suited to human memory. The single biggest reason people lose the thread is cadence: nearly all of these compounds are injected, because peptides are broken down in the gut and cannot survive as ordinary pills (PubMed 15984901), and the modern versions are engineered to last a week per shot.

That weekly rhythm is the trap. A daily pill rides on an existing routine, morning coffee, brushing your teeth, so the habit forms on its own. A once-weekly injection has nothing to attach to. There is no daily cue, and by day five the last dose feels like it could have been three days ago or ten. The chemistry that made these drugs convenient, extending a natural half-life of minutes into days (PubMed 17928588), is the same chemistry that removes the daily anchor your memory relies on.

The adherence literature is counterintuitive here. Fewer, simpler doses are generally easier to stick to; a meta-analysis of dosing frequency in cardiovascular disease found adherence falls as the number of daily doses rises (PubMed 25070671). But weekly injectables introduce a different failure mode. The problem is not too many doses to remember, it is too few, spaced too far apart to build a habit. And non-adherence is not a rare edge case: roughly half of medication taken for chronic conditions is not taken as prescribed (PubMed 16079372).

Now stack the real-world complications on top. Many people are not running one thing. They have a weekly GLP-1 agonist on one schedule, a repair peptide like BPC-157 on another, and maybe a daily compound as well, each with its own timing. Add titration, where a clinician steps the dose up on set dates, and site rotation, where you are supposed to move each injection to a fresh spot, and the mental load becomes genuinely hard to carry. That is the gap a written record closes.

What a good peptide tracking record actually contains

A useful log is not a diary. It is a short, consistent set of fields you fill in the same way every time. The value comes from consistency, not detail, a sparse record you always complete beats a rich one you abandon after two weeks. Five fields form the core:

• Compound. The exact name, so a multi-peptide record never blurs together. Ozempic and Wegovy are both semaglutide, but you still want to record which pen you used.
• Date and time. The single most important field. This is what tells you whether a dose was taken, missed, or accidentally repeated.
• Dose. Recorded exactly as your clinician set it. A log stores what happened; it never suggests a number.
• Injection site. Which area you used, so the next one goes somewhere else.
• Side effects and notes. Nausea, injection-site soreness, appetite changes, energy, anything you would otherwise forget by your next appointment.

Those five answer the questions that actually come up: did I take it, when, where, and how did I feel. Around that core, a second layer of context makes the record far more useful to review: body weight, sleep, steps, workouts, and the dates a clinician changed your dose. None of that is required, but it turns a bare checklist into a timeline you can read patterns from, and into something concrete to hand a clinician instead of a vague "I think it's been fine." For the mechanics of choosing and moving injection sites, see our guide to peptide injection sites.

Does tracking and reminding actually improve adherence?

This is the honest question, and the evidence is encouraging without being a magic wand. The clearest recent signal comes from a 2025 systematic review and meta-analysis in the Journal of Medical Internet Research, which pooled trials of medication-adherence apps and found app-based interventions improved adherence for chronic conditions (PubMed 40743450). A 2024 umbrella review in The Lancet Digital Health, synthesizing 34 separate meta-analyses, reached a similar conclusion: mobile phone interventions improved a range of outcomes across chronic diseases (PubMed 39332937).

Reminders specifically have the strongest track record. A meta-analysis in JAMA Internal Medicine found that simple text-message reminders roughly doubled the odds of medication adherence compared with no reminder (PubMed 26831740). A well-timed nudge on your injection day does the one job memory is bad at: remembering an event that happens too rarely to become automatic.

Two caveats keep this honest. First, effects vary a lot by app and by person, and a 2014 Cochrane review of adherence interventions concluded that even the better approaches produced only modest gains and that no single method reliably works for everyone (PubMed 25412402). Second, a reminder cannot fix a regimen someone has decided to stop, or one they never intended to follow. Tracking removes friction and forgetfulness. It does not manufacture motivation. What it reliably does is turn "I think I took it Tuesday" into a fact.

Spreadsheet vs notes app vs dedicated tracker

There is no single right tool, only the right trade-off for how many compounds you run and how likely you are to forget. Here is how the three common approaches actually compare on the things that matter for a weekly injectable regimen.

The pattern is clear. A spreadsheet is powerful, private if you keep it on your own device, and completely free, but it has no reminders and demands that you remember to open it, which is exactly the thing weekly dosing makes hard. A notes app is the fastest to start and the quickest to descend into an unreadable wall of text with no structure and no way to spot a missed dose. A dedicated tracker earns its place once you cross into multiple compounds, titration, and rotation, because it fixes the fields, sends the reminder, and keeps the history without you doing the scaffolding. If you run a single compound and never miss it, a spreadsheet is genuinely fine. The more moving parts, the more the dedicated option pays off.

How to track a weekly GLP-1 injection

Weekly GLP-1 shots, semaglutide and tirzepatide among them, are the clearest case for a deliberate system, because the weekly cadence is precisely what memory handles worst. The approach that holds up is boring and effective:

• Fix the day. Pick one injection day and keep it. A consistent day is easier to build a reminder around than "sometime this week."
• Set a recurring reminder for that day, and treat the notification as the trigger to act, not a suggestion to act eventually.
• Log at the moment of injection, not later. "I'll record it after dinner" is how doses become uncertain. Open the record before you inject.
• Capture date, site, and any side effects in the same pass, so the whole entry is one action.

The point of logging immediately is not neatness. It is that the record has to be trustworthy enough to answer "did I already take this week's dose?" with certainty, so you neither skip nor double up. Reporting what a trial administered, for instance the fixed weekly doses used in the semaglutide and tirzepatide obesity trials, is describing research, not a schedule for you; your own dose and day come from your clinician, and the tracker simply records them.

How to track injection-site rotation

Site rotation is the field people most often skip and most often regret. The record is simple: note which site you used each time, so the next injection lands somewhere fresh on a planned cycle rather than in the same spot by default.

The reason this matters is well documented in injection practice. Consensus injection-technique guidance recommends systematic rotation of sites (PubMed 27594187), because repeatedly injecting the same area is associated with lipohypertrophy, a build-up of thickened tissue, and measurable changes in the skin. An ultrasonographic and histological study of repeated injection without rotation documented increased skin thickness at overused sites (PubMed 35060349). Beyond the lump itself, injecting into that altered tissue can change how consistently a drug is absorbed, which is a real reason to keep the rotation honest. A tracker that shows your last site, or steps you through a rotation, turns "I think I used the left side last time" into a record you can trust. Our peptide injection sites guide covers the anatomy in more depth.

Tracking side effects and titration dates

Two things separate a log that is merely tidy from one that is actually useful at an appointment: side-effect timing and titration dates.

Side effects are worth capturing with their timing, not just their existence. Nausea in the first two days after a dose reads very differently from nausea that appears mid-week, and "the soreness started the week we changed the dose" is the kind of detail a clinician can act on but that nobody remembers a month later. Logging the effect next to the dose that preceded it builds that link automatically.

Titration, the planned stepping-up of a dose over set weeks, is the other place records fall apart. When the number changes on specific dates, an untracked regimen becomes a guessing game about which dose you are currently on. Recording the exact date a clinician moved you to a new dose keeps the timeline unambiguous and makes it obvious when the next change is due. Note again: the tracker records the titration your clinician set. It never proposes one. If you are weighing whether these compounds are even lawful to obtain where you are, that is a separate question covered in are peptides legal.

Is your health tracking data safe?

A peptide or GLP-1 log is sensitive health data, and where it lives matters. This is not hypothetical. A 2019 analysis in The BMJ examined medicines-related apps and found that the majority shared user data with third parties, and that data routinely flowed to a wider network of companies than users would expect (PubMed 30894349). "Free" health apps are often monetized precisely through that data.

The safer design is easy to describe. Prefer a record that lives on your own device rather than on a company's servers, that does not require you to create an account just to log a dose, and that has no advertising business relying on your information. Before you trust anything with an injection history, read the privacy policy and check two concrete things: where the data is stored, and whether it is ever sold or shared. A spreadsheet kept locally scores well on this by default. An app scores well only if it is built that way on purpose, which is the exception rather than the rule.

How PepMate handles peptide tracking

This is the point where we tell you what we built and why, plainly. PepMate is a private peptide and medication tracker for iPhone. It does not prescribe, recommend, or calculate dosing for anything, and it does not give medical advice. What it does is remove the friction that this whole article is about.

• Build your stack and set dose reminders. Add each compound with its own schedule and get a recurring reminder on the right day, which is the single feature the adherence evidence supports most directly (PubMed 26831740).
• Injection-site rotation notes, so the record shows where the last shot went and the next one moves on, addressing exactly the rotation problem the injection-technique guidance is concerned with (PubMed 27594187).
• Log meals, workouts, and steps, with an optional read-only Apple Health import, so activity and weight sit alongside the dose record without the app writing anything back into Health.
• Data stored on-device, no account required for tracking, no ads, no data sales, which is the on-device answer to the privacy concern the BMJ analysis raised (PubMed 30894349).
• A peptide starter library of 16 entries with PubMed-linked information, so the reference sits next to the log.

PepMate is free to download. Eligible new subscribers may receive a 3-day trial when Apple displays the offer, followed by the App Store price shown before purchase. Whether you use PepMate, a spreadsheet, or a notebook, the principle is the same: the best record is the one you actually keep, every dose, every time.

Frequently asked questions

Sources

Every claim above traces to peer-reviewed literature indexed on PubMed:

1. Evaluating the Effectiveness of Mobile Apps on Medication Adherence for Chronic Conditions: Systematic Review and Meta-Analysis — PubMed 40743450
2. Mobile phone interventions to improve health outcomes among patients with chronic diseases: an umbrella review and evidence synthesis from 34 meta-analyses — PubMed 39332937
3. Mobile Telephone Text Messaging for Medication Adherence in Chronic Disease: A Meta-analysis — PubMed 26831740
4. Interventions for enhancing medication adherence — PubMed 25412402
5. Adherence to medication — PubMed 16079372
6. The impact of dosing frequency on medication adherence in chronic cardiovascular disease: systematic review and meta-analysis — PubMed 25070671
7. New Insulin Delivery Recommendations — PubMed 27594187
8. Repeated insulin injection without site rotation affects skin thickness — ultrasonographic and histological evaluation — PubMed 35060349
9. Data sharing practices of medicines related apps and the mobile ecosystem: traffic, content, and network analysis — PubMed 30894349
10. Oral delivery of peptide drugs: barriers and developments — PubMed 15984901
11. The physiology of glucagon-like peptide 1 — PubMed 17928588

Keep reading